IL-5 Blocks Apoptosis and Tau Hyperphosphorylation Induced by Aβ Peptide in PC12 Cells
Overview
Physiology
Affiliations
The primary features of Alzheimer's disease (AD) are extracellular amyloid plaques consisting mainly of deposits of amyloid β (Aβ) peptides and intracellular neurofibrillary tangles (NFTs). Sets of evidence suggest that interleukin-5 (IL-5) is involved in the pathogenesis of AD. Herein, we investigated the protective role of IL-5 in PC12 cells, to provide new insights into understanding this disease. Western blot was employed to assess the protein levels of Bax and phospho-tau as well as phospho-JAK2; MTT assay was performed to decipher cell viability. Treatment of IL-5 decreased Aβ-induced tau phosphorylation and apoptosis, effects blunted by JAK2 inhibition. IL-5 prevents Aβ-evoked tau protein hyperphosphorylation and apoptosis through JAK2 signaling.
Safi A, Giunti E, Melikechi O, Xia W, Melikechi N Heliyon. 2025; 11(3):e42349.
PMID: 39981365 PMC: 11840181. DOI: 10.1016/j.heliyon.2025.e42349.
Motataianu A, Andone S, Stoian A, Balasa R, Hutanu A, Sarmasan E Int J Mol Sci. 2024; 25(7).
PMID: 38612591 PMC: 11011909. DOI: 10.3390/ijms25073782.
Yang X, Ye T, He Y, Wen L, Cheng X Front Neurol. 2023; 14:1183764.
PMID: 37441611 PMC: 10333586. DOI: 10.3389/fneur.2023.1183764.
FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders.
Lui A, Vanleuven J, Perekopskiy D, Liu D, Xu D, Alzayat O Pharmaceuticals (Basel). 2022; 15(12).
PMID: 36558997 PMC: 9784968. DOI: 10.3390/ph15121546.
Hoyer-Kimura C, Konhilas J, Mansour H, Polt R, Doyle K, Billheimer D J Neuroinflammation. 2021; 18(1):236.
PMID: 34654436 PMC: 8520282. DOI: 10.1186/s12974-021-02281-1.